DIGN.ST : Summary for Dignitana AB - Yahoo Finance

U.S. Markets closed

Dignitana AB (DIGN.ST)

Stockholm - Stockholm Delayed Price. Currency in SEK
Add to watchlist
18.80-0.20 (-1.05%)
At close: 11:23 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close19.00
Bid18.30 x
Ask18.80 x
Day's Range18.10 - 19.00
52 Week Range14.60 - 24.27
Avg. Volume26,735
Market Cap381.15M
PE Ratio (TTM)-13.01
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire8 months ago

    FDA-Cleared DigniCap® Scalp Cooling System Is Now Available For Women With Breast Cancer At 10 U.S. Cancer Treatment Centers

    DALLAS, March 29, 2016 /PRNewswire/ -- Dignitana Inc., a world leader in medical scalp-cooling technology, announced today that the DigniCap® scalp cooling system, which was cleared by the FDA in December to effectively reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, is now available at ten cancer treatment centers across the United States. Scalp cooling is administered alongside chemotherapy in medical infusion centers. The DigniCap® system is the first and only scalp cooling device to complete rigorous FDA clinical trials in the U.S., where seven out of 10 patients with early-stage breast cancer kept at least 50% of their hair.

  • FDA clears cold cap to save hair during breast cancer chemo
    Associated Presslast year

    FDA clears cold cap to save hair during breast cancer chemo

    WASHINGTON (AP) — Hair loss is one of the most despised side effects of chemotherapy, and now breast cancer patients are getting a new way to try to save their locks.

  • We're sorry this is all we were able to find about this topic.